Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 6Phase 3 5Phase 1 2Phase 2/3 1

Status

Active not recruiting 9Completed 6Terminated 5Withdrawn 4Recruiting 4Unknown 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Head & Neck 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1PD-L1-selected Solid Tumors 1Advanced Unresectable or Metastatic Solid Malignancy 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 280Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Completed × Tiragolumab × Clear all
NCT04665843 2026-05-05

SKYSCRAPER-09

Hoffmann-La Roche

Phase 2 Completed
123 enrolled 22 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03563716 2026-05-04

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Genentech, Inc.

Phase 2 Completed
135 enrolled 19 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04300647 2026-03-12

SKYSCRAPER-04

Hoffmann-La Roche

Phase 2 Completed
172 enrolled 27 charts
Gynecologic

Uterine Cervical Neoplasms

NCT05661578 2026-02-09

SKYSCRAPER-11

Hoffmann-La Roche

Phase 2 Completed
64 enrolled
Other solid neoplasm

PD-L1-selected Solid Tumors

NCT03977467 2025-08-27

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

SCRI Development Innovations, LLC

Phase 2 Completed
46 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04632992 2025-01-08

MyTACTIC

Genentech, Inc.

Phase 2 Completed
252 enrolled 27 charts

Advanced Unresectable or Metastatic Solid Malignancy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡